Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System
-
Nord Security reveals its greenhouse gas emissions for the first time
-
Publicis cuts the BS from AI at the Cannes Lions Festival
-
O2B Kids Opens 63rd Location in Tampa Bay
-
Humber River Health Elevates Orthopedic Surgical Care with PrecisionOS Team Training
-
Navigator Gas Announces Pricing of Upsized Secondary Public Offering by Selling Shareholder and Concurrent Repurchase of Shares by Navigator Gas
-
FTI Consulting Survey Identifies Top Operational Challenges and Opportunities for Hospital Leaders
-
HPQ Silicon Affiliate — Novacium’s GEN2 Advanced Silicon-Based Anode Material Delivers Superior Performance at 50 Cycles
-
Orezone Intersects 113.74 g/t Gold Over 8.00m in Ongoing Exploration and Provides Project Update
-
Pasinex Announces Provides Update on Status of Failure-To-File Cease Trade Order
-
Kelly Completes Sale of Ayers Group, a Division of KellyOCG, to Keystone Partners
-
Hydreight Adds The Third National Wellness Medspa Franchise for White Label Solution
-
Bombardier Unveils Newly Branded Global 7500 and Challenger 3500 Aircraft at Catarina Aviation Show in Brazil, Kicking Off Demo Tour with World-renowned Jets
-
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
-
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
-
Bread Financial™ Provides Performance Update for May 2024
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 11 06 2024] - (CGWL)
-
Invesco Ltd: Form 8.3 - Quanex building Products Corporation
-
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
-
Vertex Acquires Artificial Intelligence Tax Capabilities from Ryan, LLC
-
Velocity Clinical Research partners with Luminis Health, moves into oncology in the U.S.
-
Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting
-
Cielo Announces Binding Letter of Intent to Acquire Carseland Facility from Rocky Mountain Clean Fuels Inc. and Announces Termination of Agreements with Renewable U Energy Inc.
-
United Lithium Announces Drill Results for Lithium Pegmatites D & E Confirming Strike Length of over 4,000m at Bergby Project, Sweden
-
Green Shift Commodities Closes Sale of Berlin Royalty
-
Ero Copper's Tucumã Project Awarded Operational License - Commissioning On Track for First Copper Production Early Q3 2024
-
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
-
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
-
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
-
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients
-
Singing Machine to Acquire SemiCab, a Leading AI Logistics Technology Company
-
Dorman Products announces the grand opening of an additional USA-based drive shaft manufacturing facility
-
Ero Copper's Tucumã Project Awarded Operational License - Commissioning On Track for First Copper Production Early Q3 2024
-
Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
-
Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis
-
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
-
Bread Financial™ Signs Long-Term Agreement to Provide Dual Credit Card Program for Saks Fifth Avenue and Saks OFF 5TH
-
NodThera’s NLRP3 Inhibitor NT-0796 Meets Primary Endpoint of Inflammation Reversal in Phase Ib/IIa Trial in Obese Subjects with Cardiovascular Risk
-
KSQ Therapeutics Announces First Patient Dosed in Clinical Development Program for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy
-
RentRedi and Home Title Lock Partner to Protect Rental Property Owners from Deed Fraud and Title Theft
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Flash News: OKX Ventures Leads Seed Round Investment in Codatta, the First Decentralized Data Protocol Aiming to Build Foundational Data Infrastructure for Developers and Protocols
-
-
Karolinska Development’s portfolio company Biosergen gets final approval to test lead candidate BSG005 in patients with invasive fungal infection
-
Form 8.3 - AXA INVESTMENT MANAGERS: Spirent Communications plc.
-
Nathan's Famous, Inc. Reports Year End and Fourth Quarter Results
-
Affimed Reports First Quarter 2024 Financial Results & Business Update
